The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).

Samir P, Malireddi RKS, Kanneganti TD. · 2020

Read The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis). by Samir P, Malireddi RKS, Kanneganti TD. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7283380.txt.

Introduction

Samir, Malireddi and Kanneganti review the PANoptosome, a protein complex that drives an inflammatory form of programmed cell death. Their review appeared in Frontiers in Cellular and Infection Microbiology. The complex can run three death programs at once: pyroptosis, apoptosis, and necroptosis. Together that combined process is called PANoptosis.

Components of the complex have been tied to many human diseases, from autoinflammatory and brain disorders to cancer, infections, and metabolic disease. The authors list the likely building parts and analyze their domains and interaction motifs across species to show how the complex could assemble. Genetic evidence suggests the parts act both as scaffolding and as enzymes. They propose models for how the complex forms and fires, a step toward treatments aimed at it.

Catalog record

CREATORSamir P, Malireddi RKS, Kanneganti TD.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE64 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7283380

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis) By Parimal Samir, R K Subbarao Malireddi, Thirumala-Devi Kanneganti Published in: Frontiers in Cellular and Infection Microbiology DOI: 10.3389/fcimb.2020.00238 ABSTRACT Abstract Programmed cell death is regulated by evolutionarily conserved pathways that play critical roles in development and the immune response. A newly recognized pathway for proinflammatory programmed cell death called PANoptosis is controlled by a recently identified cytoplasmic multimeric protein complex named the PANoptosome. The PANoptosome can engage, in parallel, three key modes of programmed cell death—pyroptosis, apoptosis, and necroptosis. The PANoptosome components have been implicated in a wide array of human diseases including autoinflammatory diseases, neurodegenerative diseases, cancer, microbial infections, and metabolic diseases. Here, we review putative components of the PANoptosome and present a phylogenetic analysis of their molecular domains and interaction motifs that support complex assembly. We also discuss genetic data that suggest PANoptosis is coordinated by scaffolding and catalytic functions of the complex components and propose mechanistic models for PANoptosome assembly. Overall, this review presents potential mechanisms governing PANoptosis based on evolutionary analysis of the PANoptosome components. Keywords: PANoptosome, PANoptosis, ASC, caspase-1, RIPK1, RIPK3, ZBP1, caspase-8 INTRODUCTION Programmed cell death (PCD) is an evolutionarily conserved process that plays central roles in maintaining organismal homeostasis. Three key PCD pathways have been studied in great detail—pyroptosis (inflammasome-dependent PCD executed by gasdermin family members), apoptosis (PCD mediated by the apoptosome and executioner caspases), and necroptosis (PCD mediated by RIPK3 and the downstream effector MLKL). Previous studies have provided a foundation for us to understand the active and extensive crosstalk between the inflammasome/pyroptosis and apoptosis and necroptosis (Lamkanfi et al., 2008; Malireddi et al., 2010, 2018, 2020; Gurung et al., 2014, 2016a; Lukens et al., 2014; Kuriakose et al., 2016; Zheng et al., 2020). Some pathogenic challenges, such as influenza A virus (IAV) infection (Kuriakose et al., 2016), inhibition of the homeostasis-regulating transforming growth factor β-activated kinase 1 (TAK1) (Malireddi et al., 2018, 2020), and functional alterations in receptor-interacting serine/threonine-protein kinase (RIPK) 1 (Dannappel et al., 2014; Dillon et al., 2014; Kaiser et al., 2014; Rickard et al., 2014a; Dondelinger et al., 2019; Newton et al., 2019a; Lalaoui et al., 2020), can induce pyroptosis, apoptosis, and necroptosis together. These observations raised a question about regulation of PCD in these cases—are the three pathways activated independently of each other, or is a single cell death-inducing complex controlling all three? Studies using mice lacking Tak1 in myeloid cells and small molecule inhibitors of TAK1 kinase activity suggested the latter (Malireddi et al., 2019, 2020). This evidence led to the identification of a single cell death-inducing complex that is assembled to induce a PCD phenomenon called PANoptosis (Malireddi et al., 2019, 2020). The complex has subsequently been named the PANoptosome (Figure 1A) (Christgen et al., 2020). The PANoptosome was initially shown to contain RIPK1, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), nucleotide-binding oligomerization domain (NOD)-like receptor pyrin domain-containing 3 (NLRP3), and caspase (CASP) 8 (Malireddi et al., 2020). A subsequent study determined that RIPK3, CASP6, Z-DNA-binding protein 1 (ZBP1), and CASP1 are also components of the PANoptosome that is assembled in response to IAV infection (Zheng et al., 2020). Collectively, these studies showed that the PANoptosome contains molecules critical for pyroptosis, apoptosis, and necroptosis and is able to activate all three to execute proinflammatory cell death (Christgen et al., 2020). Therefore, PANoptosis provides a mechanism for the host to activate alternative cell death defense mechanisms if one or more of the PCD pathways are compromised by a pathogen or other blockade. In this review, we will discuss PANoptosis and the molecular components of the PANoptosome complex, including their domain structures and functions, and use evolutionary analyses to contextualize the interactions between these molecules. [Figure: The molecular components of the PANoptosome and the human health significance of PANoptosis. (A) Proposed domains of PANoptosome components required for complex assembly in response to various stimuli. PANoptosome assembly is mediated by key molecular motifs collectively called death fold domains. Genetic evidence suggests that PANoptosome activation is inhibited by TAK1, PSTPIP2, SHARPIN, HOIP, HOIL-1, and A20. (B) Defects in the PANoptosome components have been implicated in a range of human diseases.] ESTABLISHED MECHANISMS OF PANOPTOSIS Pathogen sensing by the innate immune system activates intracellular signaling cascades to induce a proinflammatory immune response. Many innate sensors also trigger PCD either by directly interacting with mediators of cell death or through the downstream effects of secreted cytokines. One pathogen that elicits proinflammatory immune responses and PCD is IAV. Yearly seasonal flu outbreaks are caused by IAV strains, but hypervirulent strains sporadically emerge and can result in catastrophic pandemics, such as the 1918 Spanish flu, which killed approximately 50 million people worldwide (Johnson and Mueller, 2002). One feature that made the Spanish flu so deadly was its ability to initiate a dramatic host inflammatory response to the virus, culminating in a rapid “cytokine storm,” severe lung tissue damage, and death. The NLRP3 inflammasome was shown to be a major antiviral host defense mechanism controlling lung inflammation during IAV infection (Kanneganti et al., 2006a,b; Thomas et al., 2009). However, the PCD induced by IAV is not entirely dependent on the NLRP3 inflammasome. The loss of a component essential for just one PCD pathway does not protect the cells from IAV-induced cell death (Kuriakose et al., 2016). Cells lacking the ability to induce pyroptosis, apoptosis, and necroptosis collectively due to genetic loss of Ripk3 and Casp8 (or Fadd) are protected (Kuriakose et al., 2016). Combinatorial pharmacological inhibition of these three PCD pathways also protects the cells. IAV-induced PCD is also dependent on type I interferon signaling, as cells lacking interferon alpha and beta receptor subunit 1 (IFNAR1) are resistant to IAV-induced cell death (Kuriakose et al., 2016). These findings suggest the existence of upstream regulator(s) controlled by type I interferon signaling. The search for the upstream molecules responsible for NLRP3 inflammasome activation and PCD identified ZBP1—cells lacking Zbp1 are completely protected from PCD (Kuriakose et al., 2016). Later studies provided additional confirmation that ZBP1 is responsible for RIPK3-dependent cell death during IAV infection (Thapa et al., 2016; Kesavardhana et al., 2017). These observations led to the first description of PANoptosis (Malireddi et al., 2019). Mechanistically, ZBP1 drives PANoptosis by recruiting RIPK3 and CASP8 to the PANoptosome upon sensing IAV infection (Kuriakose et al., 2016; Kesavardhana et al., 2017; Kuriakose and Kanneganti, 2017; Zheng et al., 2020). Although the ZBP1 PANoptosome promotes PANoptosis to shape the immune response against viral infections, its role in maintaining organismal homeostasis is increasingly being appreciated. Lethality in mice caused by the Ripk1RHIM mutation can be rescued by concomitantly deleting ZBP1 or mutating the RHIM domain in ZBP1 (Lin et al., 2016; Newton et al., 2016; Jiao et al., 2020), suggesting that RIPK1 inhibits the aberrant induction of PANoptosis by ZBP1. This evidence extends the concept of PANoptosis beyond the context of infection and shows that it can also regulate fundamental organismal processes such as development. Further evidence for the role of PANoptosis in organismal processes can be seen from studies with RIPK1. The regulation of PANoptosis by RIPK1 is essential for homeostasis, cell death, and inflammatory immune responses. The scaffolding function of RIPK1 promotes cell

Read the complete text